A phase I study of the combination of gemcitabine (G), vinorelbine (V) and cisplatin (P) in patients (pts) with solid tumors.

被引：0
|
作者：
Schrijvers, D [1 ]
Dyck, J [1 ]
Van den Brande, J [1 ]
Wilmes, P [1 ]
Korst, A [1 ]
Lardon, F [1 ]
Vermorken, J [1 ]
机构：
[1] Univ Antwerp Hosp, Dept Med Oncol, Edegem, Belgium
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
642P
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [31] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [32] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [33] A phase I safety and pharmacokinetic (PK) study of navitoclax (N) in combination with docetaxel (D) in patients (pts) with solid tumors.
    Puglisi, M.
    van Doorn, L.
    Blanco-Codesido, M.
    De Jonge, M. J.
    Moran, K.
    Yang, J.
    Busman, T.
    Franklin, C.
    Mabry, M.
    Krivoshik, A.
    Humerickhouse, R.
    Molife, L. R.
    Eskens, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [35] A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors
    Richly, H.
    Rubin, S. D.
    Madi, A.
    Jeffels, M.
    Nokay, B.
    Gibson, D.
    Weller, S.
    Scheulen, M. E.
    Plummer, R.
    EJC SUPPLEMENTS, 2010, 8 (07): : 25 - 25
  • [36] Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumors.
    Hollebecque, Antoine
    Bahleda, Rastislav
    Thery, Jean Christophe
    Faivre, Laura
    Le Deley, Marie-Cecile
    Paci, Angelo
    Varga, Andrea
    Gazzah, Anas
    Massard, Christophe
    Poinsignon, Vianney
    Malekzadeh, Katty
    Ribrag, Vincent
    Angevin, Eric
    Postel-Vinay, Sophie
    Gomez-Roca, Carlos Alberto
    Gharib, Myriam
    Dufour, Fabienne
    Soria, Jean-Charles
    Spano, Jean-Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
    Brian A. Costello
    Mitesh J. Borad
    Yingwei Qi
    George P. Kim
    Donald W. Northfelt
    Charles Erlichman
    Steven R. Alberts
    Investigational New Drugs, 2014, 32 : 710 - 716
  • [38] Pemetrexed/gemcitabine/cisplatin: Phase I trial in patients with solid tumors
    Bolling, C
    Lubbing, C
    Graefe, T
    Mack, S
    Von Scheel, J
    Muller-Hagen, S
    Blatter, J
    Depenbrock, H
    Ohnmacht, U
    Hanauske, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 218S - 218S
  • [39] Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors
    Costello, Brian A.
    Borad, Mitesh J.
    Qi, Yingwei
    Kim, George P.
    Northfelt, Donald W.
    Erlichman, Charles
    Alberts, Steven R.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 710 - 716
  • [40] Phase I pharmacokinetic study of oral vinorelbine in combination with cisplatin in patients with metastatic solid tumours
    Delord, Jean-Pierre
    Berge, Yves
    Puozzo, Christian
    Chatelut, Etienne
    Lefresne, Florence
    Bugat, Roland
    ANNALS OF ONCOLOGY, 2006, 17 : 142 - 143
12345